Clinical application of whole exome and genome sequencing in pediatric neurodevelopmental disorders | Synapse
April 25, 2026Open Access
Clinical application of whole exome and genome sequencing in pediatric neurodevelopmental disorders
Key Points
This research aims to evaluate the effectiveness of whole exome and genome sequencing in diagnosing pediatric neurodevelopmental disorders (NDDs).
Assess the effectiveness of whole exome sequencing (WES) and whole genome sequencing (WGS) in diagnosing pediatric NDDs.
Implement phenotype re-evaluation and selective genetic tests such as CMA and repeat expansion analysis.
Evaluate the improvement in diagnostic yield from these interventions.
WES and WGS significantly enhance the diagnostic yield in pediatric NDDs.
Selective genetic testing methods contribute to improved diagnostic accuracy.
Phenotype re-evaluation plays a crucial role in identifying potential genetic mutations.
Abstract
: WES and WGS are effective diagnostic tools for pediatric NDDs. Phenotype re-evaluation and the selective use of genetic tests such as CMA and repeat expansion analysis enhance diagnostic yield.